SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-032576
Filing Date
2017-05-15
Accepted
2017-05-15 08:45:40
Documents
3
Period of Report
2017-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-13076_18k.htm 8-K 23701
2 EX-99.1 a17-13076_1ex99d1.htm EX-99.1 120453
3 GRAPHIC g130761mm01i001.gif GRAPHIC 5980
  Complete submission text file 0001104659-17-032576.txt   153832
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 17841359
SIC: 2834 Pharmaceutical Preparations